Natural history of elevated creatinine levels

Canadian Family Physician

Volumn 52, Issue 10, 2006, Pages

  Marcotte, Laura ^b   Godwin, Marshall ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ADULT; AGED; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE COURSE; FATALITY; FEMALE; HEMODIALYSIS PATIENT; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEPHROLOGIST; PATIENT REFERRAL; PRIMARY MEDICAL CARE; REVIEW;

AGED; CREATININE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PRIMARY HEALTH CARE; REFERENCE VALUES; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES;

EID: 33845697913     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, et al. National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: evaluation, classification, and stratification. Ann Intern Med 2003;139:137-47.
2. United States Renal Data System. 1999 Annual data report. V. Patient mortality and survival. Am J Kidney Dis 1999;34(Suppl 1):S74-86.
3. Canadian Organ Replacement Registry, Canadian Institute for Health Information. 1997 Annual report. Don Mills, Ont: Canadian Organ Replacement Registry; 1997.
4. Schaubel DE, Morrison HI, Desmeules M, Parsons DA, Fenton SS. End-stage renal disease in Canada: prevalence projections to 2005. CMAJ 1999;160:1557-63.
5. Mendelssohn DC, Kua BT, Singer PA. Referral for dialysis in Ontario. Arch Intern Med 1995;155:2473-8.
6. Mendelssohn DC, Barrett B, Brownscombe L, Ethier J, Greenberg D, Kanani S, et al. Elevated levels of serum creatinine: guidelines for referral and management. CMAJ 1999;161:413-7.
7. Ifudu O, Dawood M, Homel P, Friedman EA. Excess morbidity in patients starting uremia therapy without prior care by a nephrologist. Am J Kidney Dis 1996;28:841-5.
8. Khan I, Catto GR, Edward N, Macleod AM. Chronic renal failure: factors influencing nephrology referral. Q J Med 1994;87:559-64.
9. Ratcliffe PJ, Phillips RE, Oliver DO. Late referral for maintenance dialysis. BMJ 1984;288:441-3.
10. Jungers P, Skhiri H, Zingraff J, Muller S, Fumeron C, Giatras I, et al. Benefits of early nephrological management in chronic renal failure [French]. Presse Med 1997;26:1325-9.
11. Ismail N, Neyra R, Hakim R. The medical and economical advantages of early referral of chronic renal failure patients to renal specialists. Nephrol Dial Transplant 1998;13:246-50.
12. Wilson R, Godwin M. End-stage renal disease. Timely, appropriate treatment is crucial [editorial]. Can Fam Physician 2000;46:511-2 (Eng), 522-4 (Fr).
13. Cockcroft DW, Gault MH. Estimation of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
14. Swedko PJ, Clark HD, Paramsothy K, Akbari A. Serum creatinine is an inadequate screening test for renal failure in elderly patients. Arch Intern Med 2003;163:356-60.
15. Duncan L, Heathcote J, Djurdjev O, Levin A. Screening for renal disease using serum creatinine: who are we missing? Nephrol Dial Transplant 2001;16:1042-6.
16. Bernstein K, Rigatto C. Nephrology care in Canada [letter]. CMAJ 2003;169:1006-7.
17. Clase CM, Garg AX, Kiberd BA. Prevalence of low glomerular filtration rate in nondiabetic Americans: Third National Health and Nutrition Examination Survey (NHANES III). J Am Soc Nephrol 2002;13(5):1338-49.